Position in AMGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$644,573
+$18,280 QoQ
Shares Held
1,780
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#2,008
of 3,139 holders
Holding Since
Mar 2022
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Landmark Wealth Management, LLC holds $7,741,817 across 9 Drug Manufacturers - General names. AMGN ranks #7 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
13,937 | $1,790,904 | |
| 2 | ABBV |
AbbVie Inc.
|
5,446 | $1,370,431 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
14,424 | $831,110 | |
| 4 | JNJ |
Johnson & Johnson
|
3,224 | $818,799 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
6,018 | $760,314 | |
| 6 | PFE |
Pfizer Inc
|
31,328 | $754,378 | |
| 7 | AMGN |
Amgen Inc
This page
|
1,780 | $644,573 | |
| 8 | GSK |
GSK plc
|
10,481 | $549,414 |
All Filings in AMGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $644,573 | 1,780 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $626,293 | 1,780 | Shares | Sole | 2026-04-29 | |
| 2022-03-31 | $274,949 | 1,137 | Shares | Sole | 2022-04-26 | |
| No filing history on record for this holder in this stock. | ||||||